For CMC patients, in addition to antifungal treatment for their fungal infection complications, some CMC patients can also receive immunotherapy by using Granulocyte colony‐stimulating factor(G‐CSF) or other cytokines. Here, CSF3 is linked to chronic mucocutaneous candidiasis.